ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 22 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

Shingleton Nominated To President’s Panel

June 10, 1977

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

NCI Offers Coded Serum Panels

May 28, 1982

Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research

June 4, 1993

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011